A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy

References

• Whitworth JA, World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92
   PubMed Web of Science ®Google Scholar
• Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation 2011;123:e18-209
   PubMed Web of Science ®Google Scholar
• Heidenreich P, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States a policy statement from the American Heart Association. Circulation 2011;123:933-44
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffairan D, Roger VL, et al. Executive summary: heart disease and stroke statistics – 2013 update: a report from the American Heart Association. Circulation 2013;127:143-52
   PubMed Web of Science ®Google Scholar
• Dorresteijn JA, van der Graaf Y, Spiering W, et al. Relation between blood pressure and vascular events and mortality in patients with manifest vascular disease: J-curve revisited. Hypertension 2012;59:14-21
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52
   PubMed Web of Science ®Google Scholar
• Epstein BJ, Shah NK, Borja-Hart NL. Management of hypertension with fixed-dose triple-combination treatments. Ther Adv Cardiovasc Dis 2013;7:246-59
   PubMedGoogle Scholar
• Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation 2012;126:2105-14
   PubMed Web of Science ®Google Scholar
• Hong SH, Wang J, Tang J. Dynamic view on affordability of fixed-dose combination anti-hypertensive drug therapy. Am J Hypertension 2013;26:879-87
   PubMed Web of Science ®Google Scholar
• Bramlage P, Ketelhut R, Fronk EM, et al. Clinical impact of patient adherence to a fixed-dose combination of olmesartan, amlodipine and hydrochlorothiazide. Clin Drug Investig 2014: published online 10 April 2014. doi: 10.1007/s40261-014-0188-z
   Google Scholar
• Jackson KC 2nd, Sheng X, Nelson RE, et al. Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care database. Clin Ther 2008;30:1558-63
   PubMed Web of Science ®Google Scholar
• Panjabi S, Lacey M, Bancroft T, Cao F. Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients. J Am Soc Hypertens 2013;7:46-60
   PubMed Web of Science ®Google Scholar
• Patel BV, Leslie RS, Thiebaud P, et al. Adherence with single-pill amlodipine/atorvastatin vs. a two-pill regimen. Vasc Health Risk Manag 2008;4:673-81
   PubMedGoogle Scholar
• Agarwal S, Tang SS, Rosenberg N, et al. Does synchronizing initiation of therapy affect adherence to concomitant use of anti-hypertensive and lipid-lowering therapy? Am J Ther 2009;16:119-26
   PubMed Web of Science ®Google Scholar
• Charlson M, Charlson R, Peterson J, et al. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 2008;61:1234-40
   PubMed Web of Science ®Google Scholar
• Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36:8-27
   PubMed Web of Science ®Google Scholar
• Baser O, Burkan A, Baser E, et al. Coronary angiography utilization and costs for coronary artery bypass graft surgery in Turkey. Cardiol Ther 2013;2:151-63
   PubMedGoogle Scholar
• Altinbas A, Baser E, Burkan A, et al. Retrospective analysis of total direct medical costs of hepatitis B patients with oral antiviral versus pegylated interferon therapy in Turkey. J Viral Hepat 2014: published online 18 February 2014. doi: doi: 10.1111/jvh.12206
   Google Scholar
• Baser O, Supina D, Wang L, Sengupta N. Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery. Curr Med Res Opin 2011;27:423-9
   PubMed Web of Science ®Google Scholar
• Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992;45:197-203
   PubMed Web of Science ®Google Scholar
• Zeng F, Patel B, Andrews L, et al. Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens. Curr Med Res Opin 2010;26:2877-87
   PubMed Web of Science ®Google Scholar
• Sherrill B, Halpern M, Khan S, et al. Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J Clin Hypertens 2011;13:898-909
   PubMed Web of Science ®Google Scholar
• Bangalore S, Ley L. Improving treatment adherence to anti-hypertensive therapy: the role of single-pill combinations. Expert Opin Pharmacother 2012;13:345-55
   PubMed Web of Science ®Google Scholar
• Düsing R. Optimizing blood pressure control through the use of fixed combinations. Vasc Health Risk Manag 2010;6:321-5
   PubMedGoogle Scholar
• Ferrario CM, Panjabi S, Buzinec P, Swindle JP. Clinical and economic outcomes associated with amlodipine/renin-angiotensin system blocker combinations. Ther Adv Cardiovasc Dis 2013;7:27-39
   PubMedGoogle Scholar
• Brixner DI, Jackson I, Kenneth C, et al. Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations. Curr Med Res Opin 2008;24:2597-607
   PubMed Web of Science ®Google Scholar
• Thom S, Poulter N, Field J, et al. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: The UMPIRE randomized clinical trial. JAMA 2013;310:918-29
   PubMed Web of Science ®Google Scholar
• Belsey JD. Optimizing adherence in hypertension: a comparison of outcomes and costs using single tablet regimens vs individual component regimens. J Med Econ 2012;15:897-905
   PubMedGoogle Scholar
• Pittman DG, Tao Z, Chen W, Stettin GD. Anti-hypertensive medication adherence and subsequent health care utilization and costs. Am J Manag Care 2010;16:568-76
   PubMed Web of Science ®Google Scholar
• Wong M, Tam WW, Cheung CS, et al. Medication adherence to first-line anti-hypertensive drug class in a large Chinese population. Int J Cardiol 2013;167:1438-42
   PubMed Web of Science ®Google Scholar
• Martin BC, Wiley-Exley EK, Richards S, et al. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother 2009;43:36-44
   PubMed Web of Science ®Google Scholar
• Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care 2009;15:457-64
   PubMed Web of Science ®Google Scholar